Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Wraith

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
JIMD Reports|April 3, 2013
A Large Intragenic Deletion in the ACADM Gene Can Cause MCAD Deficiency but is not Detected on Routine SequencingClaire Searle, Brage Storstein Andresen, Ed Wraith, et al.
The Journal of Pediatrics|March 28, 2009
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapyRobert F Wynn, J Ed Wraith, Jean Mercer, et al.
Blood|July 15, 2004
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrowRobert F Wynn, Claire A Hart, Carla Corradi-Perini, et al.
Plos One|October 23, 2013
Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrierKia J Langford-Smith, Zara Sandiford, Alex Langford-Smith, et al.
Plos One|February 8, 2014
Assessment of sleep in children with mucopolysaccharidosis type IIILouise Victoria Mahon, Michelle Lomax, Sheena Grant, et al.
Journal of Inherited Metabolic Disease|December 21, 2010
Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseasesKia Jane Langford-Smith, Jean Mercer, June Petty, et al.
Molecular Genetics and Metabolism|July 28, 2009
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB miceMarcelina Malinowska, Fiona L Wilkinson, William Bennett, et al.
Haematologica|February 29, 2012
Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapyMuhammad Ameer Saif, Brian W Bigger, Karen E Brookes, et al.
Blood|February 28, 2002
Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type IMelissa A Baxter, Robert F Wynn, Jonathan A Deakin, et al.
Plos One|December 15, 2010
Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic diseaseMarcelina Malinowska, Fiona L Wilkinson, Kia J Langford-Smith, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
JIMD Reports|April 3, 2013
A Large Intragenic Deletion in the ACADM Gene Can Cause MCAD Deficiency but is not Detected on Routine SequencingClaire Searle, Brage Storstein Andresen, Ed Wraith, et al.
The Journal of Pediatrics|March 28, 2009
Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapyRobert F Wynn, J Ed Wraith, Jean Mercer, et al.
Blood|July 15, 2004
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrowRobert F Wynn, Claire A Hart, Carla Corradi-Perini, et al.
Plos One|October 23, 2013
Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrierKia J Langford-Smith, Zara Sandiford, Alex Langford-Smith, et al.
Plos One|February 8, 2014
Assessment of sleep in children with mucopolysaccharidosis type IIILouise Victoria Mahon, Michelle Lomax, Sheena Grant, et al.
Journal of Inherited Metabolic Disease|December 21, 2010
Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseasesKia Jane Langford-Smith, Jean Mercer, June Petty, et al.
Molecular Genetics and Metabolism|July 28, 2009
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB miceMarcelina Malinowska, Fiona L Wilkinson, William Bennett, et al.
Haematologica|February 29, 2012
Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapyMuhammad Ameer Saif, Brian W Bigger, Karen E Brookes, et al.
Blood|February 28, 2002
Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type IMelissa A Baxter, Robert F Wynn, Jonathan A Deakin, et al.
Plos One|December 15, 2010
Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic diseaseMarcelina Malinowska, Fiona L Wilkinson, Kia J Langford-Smith, et al.
Pageof 3